Omniox Stock

omniox.comHealthcareFounded: 2006Funding to Date: $87.65MM

Omniox is a provider of biotherapeutics for ischemic, hypoxic, and anemic diseases in oncology, cardiovascular and stroke diseases, diabetes, trauma, surgery, and sickle cell crises with a focused on overcoming biochemical shortcomings in prior efforts at oxygen and nitric oxide delivery.

Buy or sell Omniox stock Learn more about Omniox IPO

Overview Financings Valuation

Enterprise Value (based on primary financings)

Powered by Forge Data

Enterprise Value

View Enterprise Value for Omniox.

Register Today

Team

Management Team

Michael Marletta Ph.D

Co-Founder & Chairman

Stephen Cary Ph.D

Co-Founder, Chief Executive Officer & Board Member

Jonathan Winger Ph.D

Founder & Vice President, Process Development and New Product Introduction

Board Members

Jeffrey Samberg

Acadia Woods Partners

Ajit Shah Ph.D

Michael Marletta Ph.D

John Wesley

Other companies like Omniox in the Healthcare sector

Sector

Last Round Est. Valuation

$2.15B

Sector

Last Round Est. Valuation

$3.67B

Sector

Last Round Est. Valuation

$334.19MM

Sector

Last Round Est. Valuation

$317.32MM

Mammoth Biosciences

Sector

Last Round Est. Valuation

$1.08B

Sector

Last Round Est. Valuation

$4.26B

Sector

Sector

Last Round Est. Valuation

$885.01MM

Biosplice Therapeutics

Sector

Frequently Asked Questions